Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases
- 1 December 1991
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 3 (6) , 941-948
- https://doi.org/10.1016/s0952-7915(05)80018-4
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- IL-1β synthesis by PBMC differs in response to infective and non-infective strains of Borrelia burgdorferi:
L.C. Miller, K. Georgilis, S. Isa, A.C. Steere, M.S. Klempner, C.A. Dinarello New England Medical Center, Tufts Univ, Boston MA 02111 USACytokine, 1991 - Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Regulation of Alloreactivity in Vivo by a Soluble Form of the Interleukin-1 ReceptorScience, 1990
- Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins.Journal of Clinical Investigation, 1990
- A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic isletsJournal of Autoimmunity, 1989
- Cytokines as Immune Effector Molecules in Autoimmune Endocrine Diseases with Special Reference to Insulin-Dependent Diabetes MellitusAutoimmunity, 1989
- In reply to Dr Mandrup-PoulsenEt Al.Autoimmunity, 1989
- Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type.Journal of Clinical Investigation, 1988
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988